X. Liu Et Al. , "Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway," JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.40, no.1, 2021
Liu, X. Et Al. 2021. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.40, no.1 .
Liu, X., Su, K., Sun, X., Jiang, Y., Wang, L., Hu, C., ... Zhang, C.(2021). Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.40, no.1.
Liu, ABİS Et Al. "Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway," JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.40, no.1, 2021
Liu, ABİS Et Al. "Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway." JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.40, no.1, 2021
Liu, X. Et Al. (2021) . "Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway." JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.40, no.1.
@article{article, author={ABİS DESTEK Et Al. }, title={Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway}, journal={JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH}, year=2021}